Heriot AG - Search Results

1

Molecular and genomic characterisation of a panel of human anal cancer cell lines.

Guerra GR, Kong JC, Millen RM, Read M, Liu DS, Roth S, Sampurno S, Sia J, Bernardi MP, Chittleborough TJ, Behrenbruch CC, Teh J, Xu H, Haynes NM, Yu J, Lupat R, Hawkes D, Di Costanzo N, Tothill RW, Mitchell C, Ngan SY, Heriot AG, Ramsay RG, Phillips WA. Guerra GR, et al. Among authors: heriot ag. Cell Death Dis. 2021 Oct 18;12(11):959. doi: 10.1038/s41419-021-04141-5. Cell Death Dis. 2021. PMID: 34663790 Free PMC article.

2

The impact of 18-fluorodeoxyglucose positron emission tomography-computed tomography on the staging and management of primary rectal cancer.

Davey K, Heriot AG, Mackay J, Drummond E, Hogg A, Ngan S, Milner AD, Hicks RJ. Davey K, et al. Among authors: heriot ag. Dis Colon Rectum. 2008 Jul;51(7):997-1003. doi: 10.1007/s10350-008-9244-1. Epub 2008 May 7. Dis Colon Rectum. 2008. PMID: 18461399

3

The role of intraoperative radiotherapy in solid tumors.

Skandarajah AR, Lynch AC, Mackay JR, Ngan S, Heriot AG. Skandarajah AR, et al. Among authors: heriot ag. Ann Surg Oncol. 2009 Mar;16(3):735-44. doi: 10.1245/s10434-008-0287-2. Epub 2009 Jan 14. Ann Surg Oncol. 2009. PMID: 19142683 Review.

4

The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer.

Winton Ed, Heriot AG, Ng M, Hicks RJ, Hogg A, Milner A, Leong T, Fay M, MacKay J, Drummond E, Ngan SY. Winton Ed, et al. Among authors: heriot ag. Br J Cancer. 2009 Mar 10;100(5):693-700. doi: 10.1038/sj.bjc.6604897. Br J Cancer. 2009. PMID: 19259091 Free PMC article.

5

Chemoradiotherapy in the management of primary squamous-cell carcinoma of the rectum.

Wang ML, Heriot A, Leong T, Ngan SY. Wang ML, et al. Colorectal Dis. 2011 Mar;13(3):296-301. doi: 10.1111/j.1463-1318.2009.02154.x. Colorectal Dis. 2011. PMID: 20002695

6

Intraoperative radiotherapy and colorectal cancer.

Yeung JM, Ngan S, Lynch C, Heriot AG. Yeung JM, et al. Among authors: heriot ag. Minerva Chir. 2010 Apr;65(2):161-71. Minerva Chir. 2010. PMID: 20548272 Review.

7

Using gene expression profiling to predict response and prognosis in gastrointestinal cancers-the promise and the perils.

Brettingham-Moore KH, Duong CP, Heriot AG, Thomas RJ, Phillips WA. Brettingham-Moore KH, et al. Among authors: heriot ag. Ann Surg Oncol. 2011 May;18(5):1484-91. doi: 10.1245/s10434-010-1433-1. Epub 2010 Nov 23. Ann Surg Oncol. 2011. PMID: 21104326 Review.

8

Pretreatment transcriptional profiling for predicting response to neoadjuvant chemoradiotherapy in rectal adenocarcinoma.

Brettingham-Moore KH, Duong CP, Greenawalt DM, Heriot AG, Ellul J, Dow CA, Murray WK, Hicks RJ, Tjandra J, Chao M, Bui A, Joon DL, Thomas RJ, Phillips WA. Brettingham-Moore KH, et al. Among authors: heriot ag. Clin Cancer Res. 2011 May 1;17(9):3039-47. doi: 10.1158/1078-0432.CCR-10-2915. Epub 2011 Jan 11. Clin Cancer Res. 2011. PMID: 21224373

9

Metabolic response of rectal cancer assessed by 18-FDG PET following chemoradiotherapy is prognostic for patient outcome.

Yeung JM, Kalff V, Hicks RJ, Drummond E, Link E, Taouk Y, Michael M, Ngan S, Lynch AC, Heriot AG. Yeung JM, et al. Among authors: heriot ag. Dis Colon Rectum. 2011 May;54(5):518-25. doi: 10.1007/DCR.0b013e31820b36f0. Dis Colon Rectum. 2011. PMID: 21471751

10

FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy.

Day FL, Link E, Ngan S, Leong T, Moodie K, Lynch C, Michael M, Winton Ed, Hogg A, Hicks RJ, Heriot A. Day FL, et al. Br J Cancer. 2011 Aug 9;105(4):498-504. doi: 10.1038/bjc.2011.274. Epub 2011 Jul 26. Br J Cancer. 2011. PMID: 21792197 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

402 results

Search Page